Dihydropyridine Calcium Channel Blockers Do Not Increase Risk of Pancreatic Cancer, Study Suggests
New research suggests that, contrary to previous reports, dihydropyridine calcium channel blockers do not increase the risk of pancreatic cancer.
Diagnosis & Disease Information
No Benefit Seen With Extended S-1 Chemo After Pancreatic Cancer Resection
Extending adjuvant S-1 chemotherapy beyond 6 months after resection of pancreatic ductal adenocarcinoma does not improve outcomes, a real-world study suggests.
Xeloda Labeling Updated Under FDA’s New Program for Older Oncology Drugs
Project Renewal is an Oncology Center of Excellence initiative that aims to update the labeling information for certain older oncology drugs.
Adults Lack Knowledge About Signs of Pancreatic Cancer
In a survey of more than 1000 adults, 83% said they are unaware of the signs or symptoms of pancreatic cancer.
Medicine vs Food: The Patient Care Dilemma of Financial Toxicity
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Bariatric Surgery May Reduce Risk of Pancreatic Cancer in Patients With Obesity
Bariatric surgery may reduce the risk of pancreatic cancer in patients with obesity who are younger than 50 years of age, a study suggests.
MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Radiation to Celiac Plexus Reduces Pancreatic Cancer-Associated Pain
Delivery of radiation to the celiac plexus can decrease pain and opioid use among patients with pancreatic cancer, a phase 2 study suggests.
PCOS Associated With Increased Risk of Pancreatic Cancer
A diagnosis of PCOS was associated with a 1.9-fold higher risk of pancreatic cancer in a case-control study.
Improving Cancer Care for Transgender Patients
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...